In these two tightly related papers, the authors analysed the influence of adenosine upon human GABA A receptor instability, assessed by the rundown of the GABA A currents (I GABA ) that occurs upon repeated application of GABA. I GABA were recorded from oocytes injected with membranes extracted from human epileptic brain, including pharmacoresistant mesial temporal lobe epilepsy, focal cortical dysplasia and periglioma epileptic tissues. For comparison, data were also obtained from epileptic slices obtained from neurosurgical resection in patients suffering from some of the aforementioned diseases, as well as from cortical slices of pilocarpine-treated epileptic rats and A 1 or A 2A receptor-deficient mice.
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Rundown (desensitisation) of GABAergic currents is pro-excitatory in mature neurons since it reduces the efficacy of the GABAergic signal. Accordingly, exacerbated I GABA rundown together with slow recovery is characteristic of epileptic tissue. The well-established antiepileptic action of adenosine could allow the anticipation that if any, adenosine would attenuate I GABA rundown and that A1 receptors would be involved. Surprisingly and, in my view, refreshing in the field, it was found that adenosine A 1 receptors are not involved in the effect of this endogenous purine receptor agonist. Indeed, the most consistent finding throughout the two papers is that adenosine A1 receptors do not modulate I GABA rundown, irrespectively of the model (human vs. rats or mice, type of epilepsy, injected oocytes vs. brain slices) or the approach (pharmacological vs. receptor knockout) used. All sets of data are fully consistent in what concerns the absence of modulation by A 1 receptors of GABA A receptor instability.
Contrasting with the absence of effect of a selective A 1 receptor antagonist, a blanket adenosine receptor antagonist and adenosine deaminase reduced I GABA rundown, indicating that adenosine present in the extracellular space is exacerbating GABA A receptor desensitisation, therefore highlighting a putative proconvulsant action of adenosine. Whilst trying to dissect out the types of receptors involved, no clear-cut conclusions could be drawn. The most striking case was with A 2A receptor antagonists or A 2A knockout mice. Indeed, not all A 2A receptor antagonists tested had effects in all models used, and when they did, opposite actions were often observed in subsets of cell populations.
No clear association with disease type or experimental model could be identified to explain discrepant results. Within the most extensively used model, injected oocytes, the same A 2A receptor antagonist had opposite effects in different cell subsets. In a majority of cells and models tested, A 2A receptor antagonism reduced I GABA rundown, suggesting that A 2A receptor activation by endogenous adenosine exacerbates GABA A receptor desensitisation. This could be expected since receptor desensitisation often occurs through phosphorylation (frequently mediated by cAMP and PKA, the well-known transduction pathways of A 2A receptors). However, in a minority of cells, the selective A 2A receptor antagonists exacerbated I GABA rundown and, surprisingly, data from A 2A receptor knockout mice corroborated the results obtained in this minority of cells-I GABA rundown was more pronounced in mice lacking A 2A receptors. The A 3 receptor antagonists mostly reduced the I GABA rundown but increased it if tissue was from dysplasic neocortices. The A 2B receptor was not extensively studied, but its antagonism also reduced I GABA rundown.
Combined commentary
Summarising, in what concerns a relevant dysfunctional characteristic of epileptic tissue, GABA A receptor instability, adenosine tonically exacerbated it. For sure, this action does not involve A1 receptors. It may, however, involve any other adenosine receptor. The trend is that selective antagonists of non-A1 receptors attenuate GABA A receptor desensitisation. One should, however, keep in mind that the same antagonist may have opposite effects in different cell populations within the same pathological model. Furthermore, it still remains to be understood why data from A 2A receptor knockout mice and data obtained with the A 2A receptor antagonists in the majority of cells lead to opposite conclusions. Indeed, data from A 2A receptor knockout mice would fit to the idea that A 2A receptors could have an anticonvulsant role. Irrespectively of the adenosine receptor subtype(s) involved in the modulation of GABA A receptor desensitisation in epileptic tissue and the mechanism(s) operated by them, these two papers highlight the need of thinking beyond A1 receptors whilst aiming at a full understanding of the role of adenosine in epilepsy.
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